Effect of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long term diuretic treatment.

I Canadin Task Force. Cervical cancer screening programs, 1976. Can Med Assoc j 1976; -114:1003-33. 2 Canadian Task Force. Cervical cancer screening p s: summary of the 1982 CanadianTask Force report. CanMedAssocj 1982;127:581-9. 3 Dep tofHealth and Soail Security. Heach sevies&vdop eascgfor cervical caucr. Lod: DHSS, 1984. (HC(84)17. ) 4 NlHConenssStst. Cervicalc ecreening: the Pap smear. BrMedJ 1980;281:1264-6. 5 Macgregor JE, Baird D. Detection of cvial carcinoma in the genral population. Br MadJ 1963;i: 1631-6. 6 Macgreg JE. Evaludon ofms scening programmes for cervial cancer in NE Scodand. Tonsori 1976;62:287-95. 7 Macgregor JE, Moss SM, Parkin DM, Day NE. A case-controlstudyofeva cancercrening in orth ast Scodind BrMedY 1985;2:1543-6. 8 Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia. A progress report.Jo fObs iasaGynaeology ofte tis ComBsdet 1968;75: 392-404. 9 Boye DA, Morrion B, Knom EG, Daper GJ, MiLlatAB. A coott sudy of cevical ca screeningmBritish Columbia. Cli lxveuiMod 1982;5:1-29. 10 Thorainson A, Jenison 0, B-prnason 0. Screeniig for uterine cancer in Iceland. Aca Cytol 1969-,13 302-8. 11 Johanneso G, Geiriaon G, Day NE. Th effect of m screening in Iceld 1m65-74 on the incidece and mortality ofcvical carcnoma. IxtJ Caxcer 1978;21:418-25. 12 Johannesson G, Geirsson G, Day NE, Tulinius H. Sceening for cancer of the uterine cerv in Icdand-1965-1978. Acta Obstet GynecolScand 1982;61:199-203. 13 Choi NW, Nelson NA, Abu-Zeid HAH. Cervical cytology program and its effects on cevcal cancer incidnce and mortality by geographical areas in Manitoba. In: Nieburgs HE, ed. Prvention and detection ofcancer. Vol 2, pt II. New York: Marcel Dekker, 1980:1891-907. 14 Berget A. Influence of populaion sreening on morbidity and mortality of cancr of the uterine cervixin Maribo Amt. DanMd BMBl 1979;26:91-100. 15 Lyage E, Poll P. Incdence of cevical following neptie smear. A cohort study from Manibocounty, Denmark. AmEpideasidin p . s). 16 Berget A, Mailer KA, Ol1sen JL Poll P. esrnigfor cervical crioain Maribo Amt 1971-1975. DaxnMedBull 1978;2S:232-4. 17 Norwegian Cancer Society. Mass saenmg fr canwff of sinetaramn cervixmi Oszfold cmmxgy 19591965. Report No 1. Oslo: Norwegian Cancer Society, 1967. 18 Pedersen E, Hoeg K, Kolstad P. Mmassceeningforcanceroftheuterinecervix in Ostfold county, Norway: an experiment. Second report of the Norwegian Cancer Society. Acta Obstea Gynecol Scand[Suppl] 11, 1971. 19 Ho'ugen A. Mms screening for cafice of the uternDe cervix in the county of Ostfold, Norway. In: Nieburgs HE, ed. Prevention and desecion ofcancer. New York: Marcel Dekker, 1980:1875-84. 20 Stenkvist B, BergstromR, Ekhund G, FoxCH. Papanicolaou smnearscreeningand cervical cancer. What can you expect? _JAmMedAssw 1984;252:1423-6. 21 Pettersaon F, Bj6ekbhol E, Nislund I. Evaluatio of the effect of Papnmcolaou screening in Sweden.2. Trends in incidence and mmortalt for cancer of the uterine cervix in Sweden 1958-1980. IntyjEpikdeaia(inpress): 22 Raymond L, Obradovic M, Riotton G. Une 6tude csa-tenxina pour 1'6valuation du depistag cytologique du cancer du col uterin. RevEpidemiolSantePubique 1984;32:10-5. 23 Berrino F, GattaG, D'alto M, Crosignani P, Riboli E. Efficacy fsreeningimpreventinginvasive cervical cancer. A case-control studycarried outin Milan, Italy. In: HakamoaM, MiIIerAB, Day NE, eds. Screexingfor cervical cancer. Lyon: International Agency for Research on Cancer (in press). (IARC Scientific Publications, No 76.) 24 Clarke EA, Anderson TW. Does screeningby "Pop" smearshelp prevent cervsia cancer? Acasecontrol study. Lances 1979;ii:14. 25 Hakama M, Day NE,MilkerAB, eds. Sreenmgfor cervi~cawaner. -Lyon:International Agencyfor Research on Cancer(inprea). (LARC Scientific Publicanons, No. 76.) 26 Day NE, Walter SD. Siniplsfied modelsforscreening: estimationproceduresfiommass screening programmres. Biometrics 1984;40:1-14. 27 Brookmeyer R, Day NE, Mosa S. Case-contrxotatuidies for the estimation of the natural history of precdinicaf disease from screeningdata. StauMed IM8S:127-38 . 28 Store BE, Wachoklder 5, BreslowNE. Maximum likelihood flttingofgeneralrelative risk models to stratified data. AppliedStastst 1983;32:172-81. 29 LaVecchia C,Franceschi5, Decali A, FasoliM, GentileA, TognoniG. "Pap" smearand the risk of cervical neoplasia: quantitative estimates from a case-control study. Lances 1984ssi779-82. 30 Aristizabal N, Cuello C, Correa P, Collaxos T, Haenszel W. The impact of vaginal cytology on cervical cancer rinks in Cali, Colombia. I1u4 Cancer 1984;34:5-9. 31 Hakama M. Trends in theincidenceofcervica cancerin the Nordic cotunties. In: Magnus K, ed. Trends in cancer inciene. Washington: Hemisphere, 1982:279-92.